You are here: Industry Insights > COVID-19

News List

Researchers discover new antibody that reduces severity of COVID-19 infection ExpressPharma
November 05, 2021
Scientists have identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as SARS.
UK Authorizes Merck, Ridgeback’s Oral COVID Antiviral Molnupiravir ContractPharma
November 05, 2021
Merck and Ridgeback Biotherapeutics received authorization in the UK for molnupiravir (MK-4482, EIDD-2801), the first oral antiviral medicine authorized for the treatment of mild-to-moderate COVID-19...
Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization prnasia
November 05, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion...
Booster shots recommended NMPA
November 05, 2021
China's leading pulmonologists affirmed the effectiveness of COVID-19 vaccine booster shots and warned that elderly people should pay more attention to disease prevention, as many of them have not yet been vaccinated.
Chinese mainland reports 87 locally transmitted COVID-19 cases NMPA
November 05, 2021
BEIJING -- The Chinese mainland on Wednesday reported 87 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 4.
EMA stops rolling review of Lilly’s antibodies for Covid-19 Pharmaceutical-Technology
November 04, 2021
The European Medicines Agency (EMA) has ended the rolling review of the marketing authorisation application for Eli Lilly Netherlands’ antibodies, bamlanivimab and etesevimab, to treat Covid-19.
WHO issues Emergency Use Listing for eighth COVID-19 vaccine ExpressPharma
November 04, 2021
The World Health Organization (WHO) today issued an Emergency Use Listing (EUL) for Covaxin (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2.
Liver Transplants for Alcoholic Hepatitis Up During COVID-19 Pandemic Drugs
November 04, 2021
Waiting-list registrations and liver transplants for alcoholic hepatitis (AH) have increased, exceeding the forecasted volumes, in association with increasing retail alcohol sales during the COVID-19 pandemic...
More Evidence COVID Shots Less Effective for People With Weak Immune Systems Drugs
November 04, 2021
Transplant patients and certain other folks may need four shots of COVID-19 vaccine for optimal protection, new research suggests.
Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect prnasia
November 04, 2021
Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating COVID-19 was hotly debated by live streamers on overseas...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page